In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 4, 2002, Pages 1014-1021

  Kati, Warren M ^a   Montgomery, Debra ^a   Carrick, Robert ^a   Gubareva, Larisa ^a   Maring, Clarence ^a   McDaniel, Keith ^a   Steffy, Kevin ^a   Molla, Akhteruzzaman ^a   Hayden, Frederick ^a   Kempf, Dale ^a   Kohlbrenner, William ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; A 315675; PERAMIVIR; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; DISSOCIATION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG SENSITIVITY; DRUG STRUCTURE; ENZYME ACTIVE SITE; IN VITRO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; TIME; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION;

ACETAMIDES; ALGORITHMS; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; ENZYME INHIBITORS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; KINETICS; NEURAMINIDASE; OSELTAMIVIR; PLAQUE ASSAY; PYRROLIDINES; VIRUS REPLICATION;

EID: 0036210594     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.4.1014-1021.2002     Document Type: Article

References (36)

1. Antigenic, sequence and crystal variation in influenza B neuraminidase
2. BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
3. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
4. Relationship between the inhibition constant, Ki, and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
5. Advances in influenza virus vaccine research
6. Post-antibiotic effects in experimental infection models: Relationship to in-vitro phenomena and to treatment of infections in man
7. Avídin is a slow-binding inhibitor of pyruvate carboxylase
8. Serious morbidity and mortality associated with influenza epidemics
9. 2,3-Didehydro-2,4-dideoxy-4-goanidino-N-acetyl-D-neuraminic acid is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus
10. Emergence and apparent transmission of rimantidine-resistent influenza A virus in families
11. Plaque inhibition assay for drug susceptibility testing of influenza viruses
12. Emergence and transmission of influenza A viruses resistant to amantadine and rimantidine
13. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
14. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza
15. GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains
16. Novel α- and β-amino acid inhibitors of influenza virus neuraminidase
17. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site
18. The molecular biology of influenza virus pathogenicity
19. Influenza virus neuraminidase with haemagglutinin activity
20. Resistance of influenza viruses to neuraminidase inhibitors - A review
21. Generation and characterization of variants of NWS/G70c influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu-5Ac2en
22. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection
23. The slow-binding and slow, tight-binding inhibition of enzyme-catalyzed reactions
24. Approaches to the study and analysis of the inhibition of enzymes by slow- and tight-binding inhibitors
25. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
26. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of action
27. Influenza virus vaccines
28. In vivo influenza virus inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
29. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
30. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
31. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071
32. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza
33. Rational design of potent sialidase-based inhibitors of influenza virus replication
34. Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores
35. The kinetics of reversible tight-binding inhibition
36. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro